- Home
- DXLG vs SEER Comparison
DXLG vs SEER Comparison
Compare DXLG & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXLG
- SEER
- Stock Information
- Founded
- DXLG 1976
- SEER 2017
- Country
- DXLG United States
- SEER United States
- Employees
- DXLG N/A
- SEER N/A
- Industry
- DXLG Clothing/Shoe/Accessory Stores
- SEER Medicinal Chemicals and Botanical Products
- Sector
- DXLG Consumer Discretionary
- SEER Health Care
- Exchange
- DXLG Nasdaq
- SEER Nasdaq
- Market Cap
- DXLG 128.2M
- SEER 124.9M
- IPO Year
- DXLG 1987
- SEER 2020
- Fundamental
- Price
- DXLG $1.03
- SEER $1.97
- Analyst Decision
- DXLG Buy
- SEER Hold
- Analyst Count
- DXLG 2
- SEER 1
- Target Price
- DXLG $2.75
- SEER $3.00
- AVG Volume (30 Days)
- DXLG 398.8K
- SEER 271.4K
- Earning Date
- DXLG 05-29-2025
- SEER 05-07-2025
- Dividend Yield
- DXLG N/A
- SEER N/A
- EPS Growth
- DXLG N/A
- SEER N/A
- EPS
- DXLG 0.05
- SEER N/A
- Revenue
- DXLG $467,015,000.00
- SEER $14,170,000.00
- Revenue This Year
- DXLG N/A
- SEER $23.54
- Revenue Next Year
- DXLG $3.44
- SEER $42.98
- P/E Ratio
- DXLG $20.60
- SEER N/A
- Revenue Growth
- DXLG N/A
- SEER N/A
- 52 Week Low
- DXLG $0.92
- SEER $1.56
- 52 Week High
- DXLG $3.93
- SEER $2.63
- Technical
- Relative Strength Index (RSI)
- DXLG 26.01
- SEER 52.65
- Support Level
- DXLG $0.92
- SEER $1.97
- Resistance Level
- DXLG $1.22
- SEER $2.15
- Average True Range (ATR)
- DXLG 0.15
- SEER 0.11
- MACD
- DXLG -0.01
- SEER 0.04
- Stochastic Oscillator
- DXLG 17.46
- SEER 66.04
About DXLG Destination XL Group Inc.
Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.